Cynthia Schwalm

Cynthia is a recently retired company-building biotechnology CEO specializing in commercial/operational strategy, with decades of leadership experience developing, expanding, and breathing life into various organizations such as top tier big pharma/biotech (J&J, Amgen), mid-size specialty pharmaceuticals (Ipsen SA) and start-up biotech environments. She has been characterized as a forward-thinking leader who advanced from health care provider to CEO while directing nearly every corporate function (medical, regulatory, all commercial operations, manufacturing, and all corporate business functions). Her reputation for taking decisive action and a holistic, maverick approach to inspiring change and adding value from the patient’s bedside to the boardroom has been instrumental in fueling growth for several publicly traded companies. Cynthia is a member of University of North Carolina’s Carolina Angel Network and serves on the board of the following organizations: